Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Development and validation of HPLC methods for the enantioselective analysis of fluoxetine and citalopram (CROSBI ID 499997)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Bartolinčić, Anamarija ; Vinković, Vladimir Development and validation of HPLC methods for the enantioselective analysis of fluoxetine and citalopram // 15th International symposium on pharmaceutical and biomedical analysis : abstract book. 2004. str. 159-159-x

Podaci o odgovornosti

Bartolinčić, Anamarija ; Vinković, Vladimir

engleski

Development and validation of HPLC methods for the enantioselective analysis of fluoxetine and citalopram

We have spent time exhaustively testing the conditions for the separations of the enantiomers of fluoxetine and citalopram by variation of chromatographic parameters on the set of the most important commercial chiral HPLC columns. The optimal enantioselective methods for the both compounds are validated.

enantioselective analysis; fluoxetine; citalopram

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

159-159-x.

2004.

objavljeno

Podaci o matičnoj publikaciji

15th International symposium on pharmaceutical and biomedical analysis : abstract book

Podaci o skupu

15th International symposium on pharmaceutical and biomedical analysis

poster

02.05.2004-06.05.2004

Firenca, Italija

Povezanost rada

Kemija